MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-28-2026
OPKO Health Cash and Cash Equivalents 2011-2026 | OPK
Annual Cash and Cash Equivalents OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 427 M | 95.9 M | 153 M | 135 M | 72.2 M | 85.5 M | 96.5 M | 91.5 M | 169 M | 194 M | 96.9 M | 186 M | 27.4 M | 71.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 427 M | 27.4 M | 136 M |
Quarterly Cash and Cash Equivalents OPKO Health
| 2026-Q1 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 332 M | 267 M | 429 M | 400 M | 40.6 M | 75.6 M | 139 M | 108 M | 111 M | 153 M | 181 M | 210 M | 102 M | 135 M | 149 M | 65.8 M | 89.5 M | 72.2 M | 72.2 M | 72.2 M | 72.2 M | 85.5 M | 85.5 M | 85.5 M | 85.5 M | 96.5 M | 96.5 M | 96.5 M | 96.5 M | 91.5 M | 91.5 M | 91.5 M | 91.5 M | 169 M | 169 M | 169 M | 169 M | 194 M | 194 M | 194 M | 194 M | 96.9 M | 96.9 M | 96.9 M | 96.9 M | 186 M | 186 M | 186 M | 186 M | 27.4 M | 27.4 M | 27.4 M | 27.4 M | 71.5 M | 71.5 M | 71.5 M | 71.5 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 429 M | 27.4 M | 129 M |
Cash and Cash Equivalents of other stocks in the Diagnostics research industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Burning Rock Biotech Limited
BNR
|
1.9 B | $ 17.19 | - | $ 181 M |  China |
 |
CareDx, Inc
CDNA
|
65.4 M | $ 21.01 | 0.24 % | $ 1.12 B |  USA |
 |
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
11.9 M | $ 1.57 | - | $ 2.09 M | USA |
 |
Accelerate Diagnostics
AXDX
|
34.9 M | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
55.1 M | $ 14.66 | -3.04 % | $ 443 M | USA |
 |
Castle Biosciences
CSTL
|
120 M | $ 25.22 | -1.18 % | $ 701 M | USA |
 |
Agilent Technologies
A
|
1.48 B | $ 114.96 | 2.59 % | $ 34.9 B | USA |
|
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
ICON Public Limited Company
ICLR
|
752 M | $ 112.87 | 0.8 % | $ 9.31 B |  Irlanda |
 |
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | USA |
 |
Aspira Women's Health
AWH
|
1.76 M | - | -6.19 % | $ 10.5 M | USA |
 |
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
7.7 M | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
359 M | $ 86.56 | -1.39 % | $ 5.84 B | USA |
 |
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
1.13 B | $ 138.5 | -0.63 % | $ 22 B | USA |
 |
Myriad Genetics
MYGN
|
150 M | $ 4.93 | -0.2 % | $ 457 M | USA |
 |
NeoGenomics
NEO
|
160 M | $ 8.85 | -1.67 % | $ 1.13 B | USA |
 |
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11.7 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
4.14 M | $ 18.73 | 2.8 % | $ 419 M | USA |
 |
Medpace Holdings
MEDP
|
497 M | $ 415.65 | -0.33 % | $ 12 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.79 B | $ 26.49 | 0.95 % | $ 20 B |  Niderland |
 |
Charles River Laboratories International
CRL
|
214 M | $ 174.1 | 1.02 % | $ 8.63 B | USA |
 |
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
956 M | - | - | $ 19.8 B | USA |
 |
Guardant Health
GH
|
378 M | $ 89.52 | -1.81 % | $ 11.2 B | USA |
 |
Personalis
PSNL
|
91.4 M | - | - | $ 350 M | USA |
 |
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | Israel |
 |
Interpace Biosciences
IDXG
|
2.5 M | $ 2.0 | -5.66 % | $ 8.85 M | USA |
 |
Thermo Fisher Scientific
TMO
|
9.85 B | $ 464.17 | 0.35 % | $ 175 B | USA |
 |
Senseonics Holdings
SENS
|
40.2 M | $ 4.9 | -2.2 % | $ 204 M | USA |
 |
Soleno Therapeutics
SLNO
|
70.1 M | $ 52.91 | 0.01 % | $ 2.69 B | USA |
 |
Twist Bioscience Corporation
TWST
|
183 M | $ 58.58 | 4.25 % | $ 3.5 B | USA |
 |
QIAGEN N.V.
QGEN
|
598 M | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
2.4 M | $ 2.17 | 0.46 % | $ 4.98 M | USA |
 |
Waters Corporation
WAT
|
588 M | $ 338.5 | 12.27 % | $ 20.2 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
532 M | $ 249.5 | -1.38 % | $ 20.8 B | USA |
 |
Celcuity
CELC
|
166 M | $ 142.8 | -1.5 % | $ 6.68 B | USA |
 |
Natera
NTRA
|
466 M | $ 207.48 | -1.93 % | $ 20.4 B | USA |
 |
Neogen Corporation
NEOG
|
129 M | $ 9.13 | 0.44 % | $ 1.98 B | USA |
 |
Invitae Corporation
NVTA
|
257 M | - | - | $ 21.2 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
420 M | $ 190.66 | -0.48 % | $ 21.2 B | USA |